Sandhya Sharma

1.1k total citations · 1 hit paper
21 papers, 735 citations indexed

About

Sandhya Sharma is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Sandhya Sharma has authored 21 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 12 papers in Immunology and 7 papers in Genetics. Recurrent topics in Sandhya Sharma's work include CAR-T cell therapy research (17 papers), Immune Cell Function and Interaction (11 papers) and Virus-based gene therapy research (7 papers). Sandhya Sharma is often cited by papers focused on CAR-T cell therapy research (17 papers), Immune Cell Function and Interaction (11 papers) and Virus-based gene therapy research (7 papers). Sandhya Sharma collaborates with scholars based in United States, Germany and Switzerland. Sandhya Sharma's co-authors include Malcolm K. Brenner, Maksim Mamonkin, Madhuwanti Srinivasan, Diogo Gomes‐Silva, Rayne H. Rouce, Timothy Davis, Dimitrios L. Wagner, Gang Bao, Ciaran M. Lee and Cliona M. Rooney and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Sandhya Sharma

20 papers receiving 727 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma

2025 14 citations Sandhya Sharma, Andras Heczey et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandhya Sharma United States	10	641	261	251	242	118	21	735
Diogo Gomes‐Silva United States	6	759 1.2×	312 1.2×	329 1.3×	274 1.1×	180 1.5×	9	857
Feiyan Mo United States	11	494 0.8×	192 0.7×	203 0.8×	195 0.8×	116 1.0×	13	575
Xia Mao China	16	512 0.8×	123 0.5×	235 0.9×	180 0.7×	104 0.9×	66	741
Reona Sakemura United States	13	717 1.1×	227 0.9×	249 1.0×	261 1.1×	261 2.2×	54	879
Farzana Nazimuddin United States	9	865 1.3×	262 1.0×	213 0.8×	276 1.1×	234 2.0×	11	958
Brandon Ballard United States	10	847 1.3×	259 1.0×	326 1.3×	311 1.3×	226 1.9×	16	1.0k
Anthony F. Daniyan United States	12	784 1.2×	237 0.9×	326 1.3×	363 1.5×	241 2.0×	24	1.0k
Lisa Marie Serrano United States	8	459 0.7×	169 0.6×	116 0.5×	268 1.1×	89 0.8×	9	543
Virna Marin Italy	14	948 1.5×	374 1.4×	338 1.3×	534 2.2×	217 1.8×	26	1.1k
Maria‐Luisa Schubert Germany	20	1.0k 1.6×	339 1.3×	397 1.6×	335 1.4×	291 2.5×	40	1.2k

Countries citing papers authored by Sandhya Sharma

Since Specialization

Citations

This map shows the geographic impact of Sandhya Sharma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandhya Sharma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandhya Sharma more than expected).

Fields of papers citing papers by Sandhya Sharma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandhya Sharma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandhya Sharma. The network helps show where Sandhya Sharma may publish in the future.

Co-authorship network of co-authors of Sandhya Sharma

This figure shows the co-authorship network connecting the top 25 collaborators of Sandhya Sharma. A scholar is included among the top collaborators of Sandhya Sharma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandhya Sharma. Sandhya Sharma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sharma, Sandhya, Andras Heczey, Mae Woods, et al.. (2025). Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma. Nature Medicine. 31(4). 1125–1129. 14 indexed citations breakdown →

Sharma, Sandhya, et al.. (2024). Cotargeting EBV lytic as well as latent cycle antigens increases T-cell potency against lymphoma. Blood Advances. 8(13). 3360–3371. 2 indexed citations

Ramos, Carlos A., David H. Quach, Premal Lulla, et al.. (2023). OFF‐THE‐SHELF CD30.CAR‐MODIFIED EPSTEIN‐BARR VIRUS‐SPECIFIC T CELLS (CD30.CAR EBVSTS) PROVIDE A SAFE AND EFFECTIVE THERAPY FOR PATIENTS WITH HODGKIN LYMPHOMA (HL). Hematological Oncology. 41(S2). 83–85. 8 indexed citations

Sharma, Sandhya, Mae Woods, Tim Sauer, et al.. (2023). Naive T cells inhibit the outgrowth of intractable antigen-activated memory T cells: implications for T-cell immunotherapy. Journal for ImmunoTherapy of Cancer. 11(4). e006267–e006267. 8 indexed citations

Sharma, Sandhya, Tim Sauer, Bilal Omer, et al.. (2023). Constitutive Interleukin-7 Cytokine Signaling Enhances the Persistence of Epstein–Barr Virus-Specific T-Cells. International Journal of Molecular Sciences. 24(21). 15806–15806. 4 indexed citations

Omer, Bilal, Thomas Pfeiffer, Sandhya Sharma, et al.. (2022). A Costimulatory CAR Improves TCR-based Cancer Immunotherapy. Cancer Immunology Research. 10(4). 512–524. 19 indexed citations

Quach, David H., Carlos A. Ramos, Premal Lulla, et al.. (2022). CD30.CAR-Modified Epstein-Barr Virus-Specific T Cells (CD30.CAR EBVSTs) Provide a Safe and Effective Off-the-Shelf Therapy for Patients with CD30-Positive Lymphoma. Blood. 140(Supplement 1). 412–414. 17 indexed citations

Sauer, Tim, Kathan Parikh, Sandhya Sharma, et al.. (2021). CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity. Blood. 138(4). 318–330. 142 indexed citations

Quach, David H., Carlos A. Ramos, Premal Lulla, et al.. (2021). Safety and Efficacy of Off-the-Shelf CD30.CAR-Modified Epstein-Barr Virus-Specific T Cells in Patients with CD30-Positive Lymphoma. Blood. 138(Supplement 1). 1763–1763. 6 indexed citations

10.

Heslop, Helen E., Sandhya Sharma, & Cliona M. Rooney. (2021). Adoptive T-Cell Therapy for Epstein-Barr Virus–Related Lymphomas. Journal of Clinical Oncology. 39(5). 514–524. 24 indexed citations

11.

Sharma, Sandhya, et al.. (2020). Virus-Specific T Cells for the Treatment of Malignancies—Then, Now, and the Future. Current Stem Cell Reports. 6(2). 17–29. 6 indexed citations

12.

Rouce, Rayne H., Sandhya Sharma, Nirav R. Shah, et al.. (2019). Use of highly characterized EBV-Specific T Cells outside of the immediate Post-Transplant setting. Cytotherapy. 21(5). e3–e3. 2 indexed citations

13.

Mamonkin, Maksim, Malini Mukherjee, Madhuwanti Srinivasan, et al.. (2017). Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies. Cancer Immunology Research. 6(1). 47–58. 79 indexed citations

14.

Gomes‐Silva, Diogo, Madhuwanti Srinivasan, Sandhya Sharma, et al.. (2017). CD7-edited T cells expressing a CD7-specific CAR for the therapy of T-cell malignancies. Blood. 130(3). 285–296. 317 indexed citations

15.

Rouce, Rayne H., Nirav R. Shah, Sandhya Sharma, et al.. (2017). Use of highly characterized EBV-specific T cells for treatment of EBV+ lymphoma outside of the HSCT setting. Cytotherapy. 19(5). S43–S43. 1 indexed citations

16.

Mamonkin, Maksim, Sandhya Sharma, Malini Mukherjee, et al.. (2016). 69. TNFR Costimulatory Domains Impair Expansion of CD5 CAR T Cells Due to Enhanced Fas-Mediated Apoptosis. Molecular Therapy. 24. S30–S30. 1 indexed citations

17.

Rouce, Rayne H., Birju Mehta, Sandhya Sharma, et al.. (2016). Rapidly-Generated EBV-Specific T Cells (EBVST-cells) to Treat Type 2 Latency Lymphoma. Blood. 128(22). 2990–2990.

18.

Mamonkin, Maksim, Malini Mukherjee, Sandhya Sharma, et al.. (2016). Tonic 4-1BB signaling from chimeric antigen receptors (CARs) impairs expansion of T cells due to Fas-mediated apoptosis. The Journal of Immunology. 196(1_Supplement). 143.7–143.7. 8 indexed citations

19.

Rouce, Rayne H., et al.. (2016). Recent advances in T‐cell immunotherapy for haematological malignancies. British Journal of Haematology. 176(5). 688–704. 20 indexed citations

20.

Adám, E, et al.. (1972). Seroepidemiologic Studies of Herpesvirus Type 2 and Carcinoma of the Cervix. II. Uganda<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 48(1). 65–72. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact